Trial Profile
A trial of telaprevir for the treatment of genotype 1 hepatitis c virus infection
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 29 Dec 2015 New trial record